ArticleJournal of the American Academy of Child and Adolescent Psychiatry2020
Editorial: Time for a New Conversation on Stimulant Use.
Article in Journal of the American Academy of Child and Adolescent Psychiatry, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
7 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Intentional Discontinuation of Psychostimulants Used to Treat ADHD in Youth: A Review and Analysis.Frontiers in psychiatry · 2021Pooled it
- Treatment response to supplemental nutrients for ADHD is independent of diet quality: the MADDY Study RCT.Nutritional neuroscience · 2024Trial
- Neurofeedback for Attention-Deficit/Hyperactivity Disorder: 25-Month Follow-up of Double-Blind Randomized Controlled Trial.Journal of the American Academy of Child and Adolescent Psychiatry · 2023Trial
- Micronutrients for Attention-Deficit/Hyperactivity Disorder in Youths: A Placebo-Controlled Randomized Clinical Trial.Journal of the American Academy of Child and Adolescent Psychiatry · 2022Trial
- Perspectives on ADHD in children and adolescents as a social construct amidst rising prevalence of diagnosis and medication use.Frontiers in psychiatry · 2023Article
- National Norms for the Vanderbilt ADHD Diagnostic Parent Rating Scale in Children.Journal of pediatric psychology · 2022Article
- Areas of Interest and Attitudes towards the Pharmacological Treatment of Attention Deficit Hyperactivity Disorder: Thematic and Quantitative Analysis Using Twitter.Journal of clinical medicine · 2021Article
Corrections and comments
- Commented on by
- Comment on
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Psychostimulants are one of the safest and most efficacious pharmacological interventions for a psychiatric disorder. In 1999, the groundbreaking Multimodal Treatment of Attention-Deficit/Hyperactivity Disorder (MTA) Study set the standard of care for long-term treatment for children with attention-deficit/hyperactivity disorder (ADHD).
Indexed as
Identifiers
31634569What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.